{"schema_version":"alpha-profile-public-v1","slug":"yezan-haddadin","canonical_url":"https://registry.alpha.ac/people/yezan-haddadin","as_of":"2026-09-21T19:12:02.304257+00:00","published_at":"2026-09-02T02:37:24.47089+00:00","last_reviewed_at":"2026-05-16T01:41:42.706+00:00","identity":{"display_name":"Yezan Haddadin","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"Outlook Therapeutics, Inc.","company_slug":"outlook-therapeutics-inc","exchange":"NASDAQ","ticker":"OTLK","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2017-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","effective_date":"2026-01-26","last_checked_at":"2026-04-25T00:37:01.306+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=yezan-haddadin","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=yezan-haddadin&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Mr. Haddadin has served as a Board member since October 2017 and as CEO of GMS Capital Partners LLC since July 2017. He has extensive experience in private equity and investment banking, having served as CEO of a regional investment bank and as Managing Director at Perella Weinberg Partners and Executive Director at J.P. Morgan's M&A group."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Outlook Therapeutics, Inc.","organizationId":"outlook-therapeutics-inc","title":"Director","period":"2017-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Outlook Therapeutics, Inc.","company_slug":"outlook-therapeutics-inc","exchange":"NASDAQ","ticker":"OTLK","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2017-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","effective_date":"2026-01-26","last_checked_at":"2026-04-25T00:37:01.306+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Yezan Haddadin as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:41:42.922684+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OTLK DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","published_at":"2026-01-26T00:00:00+00:00","last_checked_at":"2026-05-16T01:41:42.791534+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Yezan Haddadin currently serves as Director at Outlook Therapeutics, Inc..","claim_state":"verified","valid_from":"2026-01-26","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:41:42.876848+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OTLK DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","published_at":"2026-01-26T00:00:00+00:00","last_checked_at":"2026-05-16T01:41:42.791534+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Compensation","Executive"],"claim_text":"Yezan Haddadin serves on Compensation, Executive.","claim_state":"verified","valid_from":"2026-01-26","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:41:42.900105+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OTLK DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","published_at":"2026-01-26T00:00:00+00:00","last_checked_at":"2026-05-16T01:41:42.791534+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"GMS Capital Partners LLC","claim_text":"Yezan Haddadin is linked to GMS Capital Partners LLC as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:41:43.052691+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OTLK DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","published_at":"2026-01-26T00:00:00+00:00","last_checked_at":"2026-05-16T01:41:42.791534+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"Chief Executive Officer","claim_text":"Yezan Haddadin is also listed as Chief Executive Officer.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:41:43.0306+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OTLK DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","published_at":"2026-01-26T00:00:00+00:00","last_checked_at":"2026-05-16T01:41:42.791534+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Yezan Haddadin as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:41:42.965287+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OTLK DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","published_at":"2026-01-26T00:00:00+00:00","last_checked_at":"2026-05-16T01:41:42.791534+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Yezan Haddadin as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:41:42.942367+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OTLK DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","published_at":"2026-01-26T00:00:00+00:00","last_checked_at":"2026-05-16T01:41:42.791534+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:yezan-haddadin","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2017-01-01 · current","organization":"Outlook Therapeutics, Inc.","organization_id":"outlook-therapeutics-inc"},"claim_text":"Director at Outlook Therapeutics, Inc. (2017-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/yezan-haddadin#profile","url":"https://registry.alpha.ac/people/yezan-haddadin","dateModified":"2026-05-16T01:41:42.706+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/yezan-haddadin#person","name":"Yezan Haddadin","url":"https://registry.alpha.ac/people/yezan-haddadin","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Outlook Therapeutics, Inc.","tickerSymbol":"NASDAQ: OTLK"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2017-01-01","memberOf":{"@type":"Organization","name":"Outlook Therapeutics, Inc.","url":"https://registry.alpha.ac/companies/outlook-therapeutics-inc","tickerSymbol":"NASDAQ: OTLK"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","name":"OTLK DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/yezan-haddadin"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":9,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":3,"distinct_source_count":1,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":9,"corroborated_claims":0,"sources":3,"distinct_sources":1,"role_claims":1,"last_reviewed_at":"2026-05-16T01:41:42.706+00:00","observed_at":"2026-09-21T19:12:02.304257+00:00","freshness_days":129}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"yezan-haddadin","canonical_url":"https://registry.alpha.ac/people/yezan-haddadin"},"publication":{"published_at":"2026-09-02T02:37:24.47089+00:00","last_reviewed_at":"2026-05-16T01:41:42.706+00:00","as_of":"2026-09-21T19:12:02.304257+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/yezan-haddadin","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/yezan-haddadin","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/yezan-haddadin.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}